Bank of Montreal
BMRN icon

Bank of Montreal’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bank of Montreal’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-9,200
Closed -$664K – 3727
2013
Q3 		$664K Buy
+9,200
New +$611K ﹤0.01% 1655

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return

Bank of Montreal's BMRN Position: Q2 2026 in Review

Bank of Montreal increased its BioMarin Pharmaceuticals (BMRN) stake by 2.7% in Q2 2026, buying an estimated $95.7K and bringing the position to 65,500 shares worth $3.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1478.

Bank of Montreal first reported a position in BMRN in Q2 2013 and has held it in 53 quarters since. The position peaked at $32.8M in Q2 2015. 356 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Bank of Montreal held 65,500 shares of BioMarin Pharmaceuticals worth $3.75M as of Q2 2026.
  • Bank of Montreal bought 1,747 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $95.7K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1478 holding.
  • Bank of Montreal first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Bank of Montreal's BioMarin Pharmaceuticals position peaked at $32.8M in Q2 2015.
  • 356 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.